Edited by three pioneers in the field, each with longstanding experience in the biotech industry, and a skilled scientific writer, this is the first book to cover every step in the development and production of immunoglobulin Fc-fusion proteins as therapeutics for
human disease: from choosing the right molecular design, to pre-clinical characterization of the purified product, through to batch optimization and quality control for large-scale cGMP production. The whole of the second part is devoted to case studies of Fc-fusion proteins that are now commercially successful products. In this section, the authors, several of whom were personally involved in clinical development of the products themselves, detail the product? s background and give insight into issues that were faced and how these issues were overcome during clinical development. This section also includes a chapter on promising new developments for the future.
An invaluable resource for professionals already working on Fc-fusion proteins and an excellent and thorough introduction for physicians, researchers, and students entering the field.
Inhaltsverzeichnis
Introduction: Antibody Structure and Function (Pons, J. , Rajpal, A. , Strop, P. , Yeung, Y. A. , Chaparro-Riggers, J.)
PART I: METHODS OF PRODUCTION FOR Fc-FUSION PROTEINS
Fc-Fusion Protein Expression Technology (Berry, J. , Yang, C. , Fisher, J. , Mendoza, E. , Young, S. , Stupack, D.)
Cell Culture Based Production (Ryll, Th. , Huang, Y. -M. , Kshirsagar, R. , Woppmann, B.)
Downstream Processing of Fc-Fusion Proteins (Shukla, A. A. , Gottschalk, U.)
Formulation, Drug Product, and Delivery: Considerations for Fc-Fusion Proteins (Yeh, P. Y. , Cao, W. , Piedmonte, D. M. , Ricci, M. S.)
Quality by Design Applied to a Fc-fusion Protein: A Case Study (Broly, H. , Eon-Duval, A. , Gleixner, R. ; Valax, P. , Soos, M. , Neunstoecklin, B. , Morbidelli, M.)
Analytical Methods Used to Characterize Fc-fusion Proteins (Mulkerrin, M. , Idusogie, E.)
PART II: CASE STUDIES OF THERAPEUTIC Fc-FUSION PROTEINS
Introduction to Therapeutic Fc-fusion Proteins (Berry, J. D.)
Alefacept (Farson, D. A. , Grossman, J.)
Etanercept (Grossman, J. , Chamow, S. M.)
Abatacept and Belatacept (Peach, R. J.)
Aflibercept (Chamow, S. M. , Linderholm, A. L.)
Recombinant Factor VIII- and Factor IX-Fc-Fusions (Peters, R.)